Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-20-000029 General Corporate
Debt relative to revenue 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
151.77% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.94% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.52% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-13.92% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
83.97% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
33.82% · CORE · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.06% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.32% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.69% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 150.80%
Current 151.77%
Delta 0.97% Capex Intensity Decreased
Previous 3.10%
Current 1.94%
Delta -1.16% Cash Generation Increased
Previous -32.03%
Current 25.52%
Delta 57.55% Growth Decreased
Previous 3.96%
Current -13.92%
Delta -17.88% Inventory Pressure Increased
Previous 74.72%
Current 83.97%
Delta 9.25% Margin Increased
Previous 33.36%
Current 33.82%
Delta 0.46% Profitability Decreased
Previous 12.05%
Current 10.06%
Delta -1.99% R And D Intensity Increased
Previous 3.04%
Current 3.32%
Delta 0.28% Sbc Intensity Increased
Previous 0.56%
Current 0.69%
Delta 0.14% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.